| Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings S Bonache, I Esteban, A Moles-Fernández, A Tenés, L Duran-Lozano, ... Journal of cancer research and clinical oncology 144, 2495-2513, 2018 | 76 | 2018 |
| Computational tools for splicing defect prediction in breast/ovarian cancer genes: how efficient are they at predicting RNA alterations? A Moles-Fernández, L Duran-Lozano, G Montalban, S Bonache, ... Frontiers in genetics 9, 366, 2018 | 63 | 2018 |
| Functional dissection of inherited non-coding variation influencing multiple myeloma risk R Ajore, A Niroula, M Pertesi, C Cafaro, M Thodberg, M Went, EL Bao, ... Nature communications 13 (1), 151, 2022 | 29 | 2022 |
| Germline variants at SOHLH2 influence multiple myeloma risk L Duran-Lozano, G Thorleifsson, A Lopez de Lapuente Portilla, A Niroula, ... Blood Cancer Journal 11 (4), 76, 2021 | 14 | 2021 |
| Alternative transcript imbalance underlying breast cancer susceptibility in a family carrying PALB2 c.3201+5G>T L Duran-Lozano, G Montalban, S Bonache, A Moles-Fernández, A Tenés, ... Breast Cancer Research and Treatment 174, 543-550, 2019 | 8 | 2019 |
| Deciphering the genetics and mechanisms of predisposition to multiple myeloma M Went, L Duran-Lozano, GH Halldorsson, A Gunnell, ... Nature Communications 15 (1), 6644, 2024 | 5 | 2024 |
| 164P Incorporation of the polygenic risk score (PRS) in breast cancer (BC) risk estimation among carriers of a moderate penetrance pathogenic variant (MPPV) MAR Aron, L Duran-Lozano, A López-Fernández, E Darder, R Alfonso, ... ESMO Open 9, 2024 | | 2024 |
| Genetic predisposition for Multiple Myeloma. Identification and functional characterization of risk variants L Duran Lozano Lund University, Faculty of Medicine Doctoral Dissertation Series, 2022 | | 2022 |
| Author Correction: Germline variants at SOHLH2 influence multiple myeloma risk L Duran-Lozano, G Thorleifsson, A Lopez de Lapuente Portilla, A Niroula, ... Blood Cancer Journal 11 (11), 181, 2021 | | 2021 |
| Meta-GWAS of multiple myeloma patients fromthe Nordic Region identifies a new risk locus in chromosome 13 L Duran-Lozano, G Thorleifsson, AL de Lapuente Portilla, E Johnsson, ... European Journal of Human Genetics 28 (Suppl. 1), 518, 2020 | | 2020 |
| Radiogenomics: role of non-coding RNA genes in increased radiotherapy sensitivity L Duran-Lozano, V Reyes, M Mollà, MJ Fuentes-Raspall, M Altabas, ... Radiotherapy and Oncology 123, S529-S530, 2017 | | 2017 |
| Exploring the Potential of Combining Non-Coding Rna Polymorphisms and Clinical Data in Predicting Radiotherapy-Induced Toxicity Among Breast Cancer Patients E Aguado-Flor, V Reyes, V Navarro, M Mollà, ME Aguado-Barrera, ... | | |
